SOURCE: Protectus Medical Devices, Inc.

October 21, 2010 07:30 ET

Protectus Medical Devices, Inc. Files for Patent Protection for Its Safety Syringe in Taiwan: International Patent Initiative Is Commenced

Patent Protection Sought in Taiwan Parallels the Most Recent Granting by the U.S. Patent and Trademark Office of U.S. Patent No. 7,799,002 (Safety Syringe) for the Company's Automatic, Self-Sheathing Safety Syringe

MINNEAPOLIS, MN--(Marketwire - October 21, 2010) -  Protectus Medical Devices, Inc. (OTCQB: PTMD) (PINKSHEETS: PTMD), a developer and marketer of innovative safety medical devices, announces that the Company's prior filed application for patent protection in the country of Taiwan, which corresponds to the recently granted U.S. Patent No. 7,799,002 ("Safety Syringe"), has now been documented in the Official Gazette of the Taiwan Patent Office and is undergoing substantive examination. Protectus Medical Devices is seeking the same patent rights and protection under the Taiwan patent filing as was granted in the United States. This U.S. Patent provides 20 years of patent protection for the unique spring structure central to the Company's new automatic, self-sheathing Safety Syringe.

Protectus CEO, John Salstrom, Ph.D., said, "This application is part of a broad international undertaking by Mr. Jack Dillard, COO and inventor of the Protectus Safety Syringe, to secure for the Company full patent protection and rights under international law, based on the claims and protection granted here in the United States." Dr. Salstrom went on to say, "We currently have a PCT patent application on file, which provides patent pending status for the same invention in 140 additional countries."

In conclusion, Dr. Salstrom stated, "Protectus Medical Devices intends to manufacture and sell its family of safety syringes in the United States and around the world. This roll out of international patent filings by Jack Dillard will continue as the Company seeks to protect its intellectual property while positioning itself for sales in the global economy."

In addition to being cost-effective, there are several advantages to the Company's lead product, the Protectus Safety Syringe, namely, the device:

  • Functions as a standard hypodermic syringe with its added safety features
  • Is fully automatic, self-sheathing as defined in the OSHA Mandate
  • The safety feature engages automatically should the end-user lose control of the device
  • Is user-friendly and requires only minimal training and in-service instruction
  • Allows the needle to be changed safely without exposing an unprotected needle
  • Has a permanent lock that is easily deployed after injection
  • Complies with federal and state laws and the OSHA mandate
  • Is a universal device that can be used in essentially all applications requiring the use of hypodermic syringes, e.g, intramuscular, intravenous, and subcutaneous
  • Will accept any and all manufacturers' needles of all common sizes using Luer Lock fittings

The family of Protectus Safety Syringes, including the two Safety Dental Syringes, the Safety IV Catheter and the Safety Phlebotomy Device, should prevent needlestick injuries and save the lives of doctors, nurses and healthcare workers across the nation and worldwide.

About Protectus Medical Devices, Inc.
Protectus Medical Devices, Inc. (OTCQB: PTMD) (PINKSHEETS: PTMD) (formerly, E-18 Corp.), operating through its wholly owned subsidiary, SquareOne Medical, Inc., develops and markets innovative safety medical percutaneous devices that, collectively, have the potential to dramatically reduce needlestick injuries for medical professionals worldwide. In the nearly $5 billion global hypodermic syringe market, the Protectus Safety Syringe, the Company's lead product, is the only fully automatic, self-sheathing hypodermic safety syringe that currently meets the functional definition of "Self-sheathing" mandated by the U.S. Federal Government. None of the manufacturers of other devices on the market can make this claim. Protectus Medical Devices has successfully patented its automatic, self-sheathing hypodermic safety syringe product, and, based on the results of full comparison clinical trials, the Protectus Safety Syringe (formerly the SquareOne Safety Syringe) has received the required 510(k) permission from the U.S. FDA to manufacture and market the device in the U.S. More information about the Company may be found at

Forward-Looking Statements
This release contains "forward-looking statements" for purposes of the Securities and Exchange Commission's "safe harbor" provisions under the Private Securities Litigation Reform Act of 1995 and Rule 3b-6 under the Securities Exchange Act of 1934. These forward-looking statements are subject to various risks and uncertainties that could cause the business and financial results of Protectus Medical Devices, Inc. to differ materially from those currently anticipated, including the risk factors identified in the filings of Protectus Medical Devices, Inc. with the Securities and Exchange Commission.

Contact Information

  • Contacts:

    John S. Salstrom, Ph.D.
    President and CEO
    Protectus Medical Devices, Inc.

    The Investor Relations Group
    Adam Holdsworth or James Carbonara